More relief for Dupixent as FDA pushes back Lilly, Pfizer eczema decisions on safety concerns

  • by
More relief for Dupixent as FDA pushes back Lilly, Pfizer eczema decisions on safety concerns
aliu
Wed, 04/07/2021 – 10:03